However, determining the precise origin of sHGF in ovarian cancer patients is complex because elevated HGF levels are not unequivocally specific for cancer, as they were also reported in infections or graft‐versus‐host disease [35, 36]. This evidence concerns the gene HGF and ovarian carcinoma.